Lebwohl M, Strober B, Langley RG, Okubo Y, Foley P, Warren R, Peterson L, Cross N, Wiegratz S, Deherder D, Thaçi D. Bimekizumab 3-year Safety and Tolerability in Moderate to Severe Plaque Psoriasis: Long-term Pooled Analysis from Five Phase 3/3b Trials. J of Skin [Internet]. 2024 Jan. 16 [cited 2024 Jul. 3];8(1):s305. Available from: https://jofskin.org/33014/index.php/skin/article/view/2451